Nutex Health NUTX Estimates

NASDAQ NUTX
$197.45 +5.45 (+2.84%)
As of: Sep 3, 2026 · 3:59 PM EDT
Analyst Estimates

Nutex Health Inc. Revenue Estimates

Periods 19
Next Period Q2 26
Consensus 221.14 M

Analysts expect Nutex Health Inc. to report revenue of 221.14 M for Q2 26, against a range of 203.14 M to 239.14 M. The most recent reported quarter, Q1 26, came in at 216.49 M, a 9.6% miss against the 239.51 M consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 76.08 M78.79 M257.62 M211.79 M243.99 M267.80 M151.70 M216.49 M--------
High Estimate 69.27 M84.50 M78.77 M149.93 M262.12 M235.68 M290.45 M247.26 M239.14 M224.66 M264.83 M244.60 M288.59 M310.93 M347.01 M312.20 M
Low Estimate 62.34 M69.60 M73.53 M137.27 M244.97 M216.37 M247.68 M231.75 M203.14 M190.20 M218.86 M217.10 M269.48 M269.08 M315.28 M278.00 M
Consensus Estimate 65.80 M77.05 M76.15 M143.60 M253.55 M226.03 M269.07 M239.51 M221.14 M207.43 M241.84 M230.85 M279.04 M290.01 M331.15 M295.10 M
Analyst Estimates

Nutex Health Inc. Earnings Per Share (EPS) Estimates

Periods 19
Next Period Q2 26
Consensus 4.78

Analysts expect Nutex Health Inc. to report earnings per share of 4.78 for Q2 26, against a range of 4.44 to 5.12. The most recent reported quarter, Q1 26, came in at 6.52, a 54.5% beat against the 4.22 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -0.07-1.7211.122.56-2.957.761.696.52--------
High Estimate -0.29-0.24-0.113.09-1.391.905.714.495.125.535.076.465.246.816.487.96
Low Estimate -0.31-0.26-0.132.87-1.631.624.913.954.444.774.635.544.626.315.606.74
Consensus Estimate -0.30-0.25-0.122.98-1.511.765.314.224.785.154.856.004.936.566.047.35